CA1205386A - Drugs containing a psoralene derivative - Google Patents

Drugs containing a psoralene derivative

Info

Publication number
CA1205386A
CA1205386A CA000428960A CA428960A CA1205386A CA 1205386 A CA1205386 A CA 1205386A CA 000428960 A CA000428960 A CA 000428960A CA 428960 A CA428960 A CA 428960A CA 1205386 A CA1205386 A CA 1205386A
Authority
CA
Canada
Prior art keywords
drug according
methoxypsoralene
drug
exposure
therapeutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000428960A
Other languages
English (en)
French (fr)
Inventor
Jean-Jacques Goupil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1205386A publication Critical patent/CA1205386A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA000428960A 1982-04-09 1983-05-26 Drugs containing a psoralene derivative Expired CA1205386A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8206262A FR2524801B1 (fr) 1982-04-09 1982-04-09 Medicaments contenant un derive du psoralene
BE0/210731A BE896700A (fr) 1982-04-09 1983-05-09 Medicaments contenant un derive du psoralene.

Publications (1)

Publication Number Publication Date
CA1205386A true CA1205386A (en) 1986-06-03

Family

ID=36782343

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000428960A Expired CA1205386A (en) 1982-04-09 1983-05-26 Drugs containing a psoralene derivative

Country Status (7)

Country Link
JP (1) JPH0653664B2 (ja)
AU (1) AU559029B2 (ja)
BE (1) BE896700A (ja)
CA (1) CA1205386A (ja)
CH (1) CH656801A5 (ja)
FR (1) FR2524801B1 (ja)
GB (1) GB2140686B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9106365D0 (en) * 1991-03-26 1991-05-15 Bioglan Lab Ltd An emollient for use with ultraviolet light
FR2695036B1 (fr) * 1992-09-03 1994-10-28 Goupil Jean Jacques Huile contenant du 5-méthoxypsoralène à une concentration de 60 à 100 PPM et son utilisation pour le traitement du psoriasis.
US5556612A (en) * 1994-03-15 1996-09-17 The General Hospital Corporation Methods for phototherapeutic treatment of proliferative skin diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2406444A1 (fr) * 1977-10-21 1979-05-18 Goupil Jean Jacques Nouveau medicament contenant un derive du psoralene
LU80347A1 (fr) * 1977-10-21 1979-03-16 Goupil J 5-methoxy-psoralene comme nouveau medicament et procede de synthese

Also Published As

Publication number Publication date
FR2524801A1 (fr) 1983-10-14
GB2140686A (en) 1984-12-05
AU559029B2 (en) 1987-02-19
GB2140686B (en) 1986-09-17
GB8315070D0 (en) 1983-07-06
JPH0653664B2 (ja) 1994-07-20
CH656801A5 (fr) 1986-07-31
FR2524801B1 (fr) 1985-08-30
BE896700A (fr) 1983-09-01
AU1490583A (en) 1984-11-29
JPS59222413A (ja) 1984-12-14

Similar Documents

Publication Publication Date Title
US4826830A (en) Topical application of glyciphosphoramide
US4753958A (en) Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
AU597144B2 (en) Use of tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis
Grimaitre et al. Topical colchicine therapy for actinic keratoses
US4970230A (en) Drugs containing a psoralene derivative
AU2008324033B2 (en) Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias
CA1205386A (en) Drugs containing a psoralene derivative
US7521065B2 (en) Compositions for the treatment and prevention of cancer
Joy et al. Embelin (2, 5-dihydroxy-3-undecyl-p-benzoquinone): a bioactive molecule isolated from Embelia ribes as an effective photodynamic therapeutic candidate against tumor in vivo
Kalz Observations on grenz ray reactions
Price et al. The treatment of mycosis fungoides with ointment-based mechlorethamine
US5200425A (en) Drugs containing a psoralene derivative
Leenutaphong et al. Fenofibrate-induced photosensitivity
Briffa et al. Photochemotherapy in psoriasis: a review
US11318161B2 (en) Methods of treating basal cell carcinoma and glioblastoma
US10369170B1 (en) Methods of treating basal cell carcinoma and glioblastoma
Pathak et al. Photochemotherapeutic, photobiological, and photochemical properties of psoralens
GEORGE et al. Treatment of vitiligo with psoralen derivatives
US20080038376A1 (en) Anti-cancer composition and method for using the same
Luce-Clausen Clinical aspects of ultraviolet therapy
Reshad et al. Does UV‐A potentiate ‘short contact’dithranol therapy?
US20170296662A1 (en) Use of alpha-(8-quinolinyloxy) mono-substituted phthalocyanine zinc for treatment of psoriasis
Berman et al. Actinic keratoses: The latest in therapy
RU2088247C1 (ru) Способ повышения эффективности лучевой терапии
Saltzer et al. Selectivity of Fluorouracil in Treatment of Actinic Keratoses

Legal Events

Date Code Title Description
MKEX Expiry